Frazier Healthcare Partners
Edit

Frazier Healthcare Partners

https://www.frazierhealthcare.com
Last activity: 21.05.2025
Active
Founded in 1991, Frazier Healthcare Partners is a leading provider of growth and venture capital to healthcare companies. With over $7.1 billion total capital raised, Frazier has invested in over 200 companies, with investment types ranging from company creation and venture capital to buyouts of profitable lower-middle market companies. The firm’s Growth Buyout team invests in healthcare and pharmaceutical services, medical products and related sectors. The Life Sciences team invests in therapeutics and related areas that are addressing unmet medical needs through innovation. Frazier has offices in Seattle, WA, and Menlo Park, CA, and invests broadly across the U.S., Canada and Europe.

For more information about Frazier Healthcare Partners, visit the company's website at www.frazierhealthcare.com.
Portfolio
1
Persons
10
Mentions
118
Location: United States, Washington, Seattle
Employees: 51-200
Founded date: 1991
Investment Type: Venture Capital
Investment Stage: Series A

Portfolio 1

DateNameWebsiteTotal RaisedLocation
31.05.2023Carmot The...carmot.us$150M-

Persons 10

DateFirst NameLast NameTitleLinkedInLocation
-JohnGrottingSenior Adv...linkedin.c...-
-RyanLuceroPartnerlinkedin.c...-
-ShyamalSwamiPrincipallinkedin.c...-
-MichaelMachakSenior Ass...linkedin.c...-
-BrianMorfittGeneral Pa...linkedin.c...-
-JoeWhittersCoE - Part...-
-HarishVenkataCoE - Dire...-
-ClarissaBermanVice Presi...linkedin.c...-
-PhilipZaorskiPartnerlinkedin.c...-
-BenMagnanoManaging P...linkedin.c...-

Mentions in press and media 118

DateTitleDescription
21.05.2025India Digest: Blackstone leads race for AGS Health buyout; CleanMax eyes IPOBlackstone has emerged as the leading contender in the high-profile sale process of AGS Health, a healthcare IT services company owned by EQT. Separately, CleanMax Enviro Energy Solutions is understood to have roped in six bankers to float ...
31.03.2025The Surge of Private Equity: A New Era of Investment OpportunitiesIn the world of finance, private equity is a powerful engine. It drives growth, fuels innovation, and reshapes industries. Recently, two firms have made headlines, showcasing the dynamic landscape of private equity. New State Capital Partne...
28.03.2025Frazier Healthcare Partners: Strategic Minority Investment Raised From Petershill At Goldman Sachs AlternativesFrazier Healthcare Partners, a Seattle-based healthcare-focused private capital firm, announced a passive and minority investment from Petershill at Goldman Sachs Alternatives. The terms of the deal were undisclosed. Launched in 1991, Frazi...
20.03.2025Frazier Healthcare Partners Receives Strategic Minority Investment from Petershill at Goldman Sachs AlternativesFrazier Healthcare Partners, a Seattle-based, healthcare-focused private capital firm, received a passive, minority investment from Petershill at Goldman Sachs Alternatives. The amount of the deal was not disclosed. This passive minority in...
04.12.2024Maze Therapeutics Secures $115 Million to Revolutionize Kidney Disease TreatmentMaze Therapeutics, a beacon of innovation in the biopharmaceutical landscape, has successfully raised $115 million in a Series D financing round. This funding marks a significant milestone for the South San Francisco-based company, which is...
03.12.2024Maze Therapeutics: $115 Million (Series D) Raised To Develop Precision MedicineMaze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and metabolic diseases, announced the ...
24.11.2024Frazier Healthcare Partners Hits $2.3 Billion Milestone with New FundFrazier Healthcare Partners has struck gold again. The Seattle-based private equity firm recently closed its latest flagship fund, the Frazier Healthcare Growth Buyout Fund XI, L.P. (FHGB XI), raising a staggering $2.3 billion. This fund, o...
21.11.2024Frazier Healthcare Partners: $2.3 Billion 11th Growth Buyout Fund ClosedFrazier Healthcare Partners, a dedicated healthcare private equity firm, announced the closing of its latest flagship fund, Frazier Healthcare Growth Buyout Fund XI, L.P. (FHGB XI). FHGB XI was significantly oversubscribed, hitting a hard c...
21.11.2024Frazier Healthcare Partners Closes $2.3 Billion 11th Growth Buyout FundFrazier Healthcare Partners, a Seattle, WA-based dedicated healthcare private equity firm, announced the close of its latest flagship fund, Frazier Healthcare Growth Buyout Fund XI, L.P. (FHGB XI). Limited partners include public pension fu...
30.10.2024GlycoMimetics To Acquire Crescent BiopharmaGlycoMimetics (NASDAQ: GLYC), a Rockville, MD-based late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers, acquired Crescent Biopharma, Inc., a biotechnology company advancing a pipeli...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In